Minerva S.A (BEEF3)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 4.270 |
|---|---|
| 52-week range | 2.970 – 7.580 |
| Return, 1 month / 3 months | +6.2% / +19.9% |
| Return, 1 year / 3 years | −37.5% / −40.0% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 45.8% |
| Worst drawdown (1 year) | -57.7% |
| Average daily value traded | 82.02M BRL |
| Dividend yield | 4.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Minerva is a Brazilian meat company that slaughters cattle and processes beef at plants in Brazil and neighbouring South American countries. It produces fresh and chilled beef cuts, offal and other cattle by-products, and it exports much of its output to customers in South America, the Middle East and other overseas markets. The company is based in Brazil and serves wholesale buyers, distributors and food companies rather than individual shoppers.
Minerva S.A trades under the code BEEF3 on the B3 Stock Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Minerva S.A (BEEF3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 4.270 on 23 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 947 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 37.5% and over the last three months it rose 19.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 26 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.2% | ||
| From 52-week high | -42.6% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 19.9% | ||
| 6-month return | 7.9% | ||
| 12-month return, skipping the last month | -41.2% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 45.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.7% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 82.02M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | +6.2% |
| 3 months | +19.9% |
| 6 months | +7.9% |
| 1 year | −37.5% |
| 3 years | −40.0% |
| 5 years | −45.7% |
Signals
| 50-day / 200-day average | 3.916 / 4.261 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.202 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Apr 2026 | BRL 0.0312 |
| 15 Dec 2025 | BRL 0.1646 |
| 14 Aug 2023 | BRL 0.1943 |
| 18 Apr 2023 | BRL 0.3566 |
| 17 Aug 2022 | BRL 0.2192 |
| 27 Apr 2022 | BRL 0.3423 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.